Antioksidacijski učinak nove intramamarne formulacije na bazi pčelinjih proizvoda Apimasta® u muznih krava. by Jelena Šuran et al.
Veterinarski arhiV 90 (3), 225-233, 2020
225ISSN 0372-5480
Printed in Croatia
The antioxidant effect of the novel bee-product based intramammary 
formulation Apimast® in dairy cattle
Jelena Šuran1*, Jasna Aladrović2, Blanka Beer Ljubić3, Josipa Vlainić4, Marija Mamić5, 
Božo Radić6, Goran Bačić7, Nino Mačešić7, Miroslav Benić8, Antun Kostelić9, Frane Božić1, 
Hrvoje Pavasović1, and Lada Radin2
1Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Zagreb,  
Zagreb, Croatia
2Department of Physiology and Radiobiology, Faculty of Veterinary Medicine, University of Zagreb,  
Zagreb, Croatia
3Clinic for Internal Diseases, Faculty of Veterinary Medicine, University of Zagreb, Zagreb, Croatia 
4Division of Molecular Medicine, Institute Ruđer Bošković, Zagreb, Croatia 
5Clinic for Surgery, Orthopaedics and Ophthalmology, Faculty of Veterinary Medicine, University of Zagreb, 
Zagreb, Croatia
 6Hedera Ltd., Split, Croatia
7Clinic for Reproduction and Obstetrics, Faculty of Veterinary Medicine, University of Zagreb, Croatia
8Department for Bacteriology and Parasitology, Croatian Veterinary Institue, Zagreb, Croatia
9Department of Animal Science, Faculty of Agriculture, University of Zagreb, Croatia
_____________________________________________________________________________
ŠuRAN, J., J. ALAdRoVić, B. BeeR LJuBić, J. VLAiNić, M. MAMić, B. RAdić, G. BAčić, N. 
MAčeŠić, M. BeNić, A. KosTeLić, F. Božić, H. PAVAsoVić, L. RAdiN: The antioxidant effect of 
the novel bee-product based intramammary formulation Apimast® in dairy cattle. Vet. arhiv 90, 225-233, 2020.
ABsTRACT
The aim of this study was to determine the antioxidant effect of the novel bee-product based intramammary 
formulation Apimast® on the oxidative status of dairy cows. Apimast® was administered intramammarily three times 
at 12 h intervals to 10 dairy cows on each of the three dairy farms. The oxidative status markers and some metabolic 
parameters were determined in the milk (GSH-Px, d-ROM, SOD, BAP, TAS) and in the serum (SOD, GSH-Px, NEFA, 
BHB, glucose). The results showed that the effect of Apimast® was mostly local, regardless of the concentration used 
(3% and 1%) as there was an increase in the concentration of GSH-Px and TAS in the milk, but not in the blood. It is 
also of a short-term nature since the values of these parameters were significantly lower 7 days after application. The 
expected connection between the increase of ROM in milk samples from the microbiologically positive quarters was 
not found. The results of this study confirm the local antioxidant effect of Apimast® in the udder, with implications for 
non-antibiotic subclinical mastitis treatment.
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introduction
With the development of the modern dairy 
industry and the ever-increasing demands of the 
market over the last forty years, selection of cows for 
high milk production leads to the doubling of milk 
production per cow (OLTENACU and ALGERS, 
2005). Mastitis, inflammation of the mammary 
gland, is the most common health problem of dairy 
cows, with special importance in high-yield dairy 
herds. The financial cost of mastitis can be attributed 
to production losses, extensive treatment costs and 
negative impacts on animal welfare, among others 
(NIELSEN et al., 2010). The aetiology of mastitis 
is complex and is considered to be a result of the 
interaction between the hosts, microorganisms, 
the environment, and farming (BAČIĆ, 2009). 
Established clinical mastitis therapy implies the 
use of antibiotics, whereby the choice of therapy 
is adjusted to the course of the inflammation and 
the cause. On the other hand, subclinical mastitis, 
considered to be a major problem on large, high-
yield dairy farms due to reduced milk production 
and the high number of somatic cells (reduced milk 
quality), is not treated since the cost of discarded 
milk outweighs the benefits of antimicrobial 
therapy (SANDGREN, 2008). Also, due to the 
increasing problem of antibiotic resistance, there 
is a trend (and regulatory pressure) towards 
minimizing antibiotic use in veterinary medicine, 
including dairy production, so new, non-antibiotic 
or antibiotic alternatives for mastitis treatment 
are being studied (PYÖRÄLÄ, 2002; VARELLA 
COELHO et al., 2007; WU, 2007). 
Apimast® is a novel bee-product based 
intramammary formulation, developed for mastitis 
treatment and prevention. The product has not 
been authorized as a veterinary medicinal product 
(VMP), but is being studied extensively as the first 
cost-effective intramammary antibiotic alternative 
(ŠURAN et al., 2015; 2016). The main active 
components of the product are polyphenols from 
standardized poplar type propolis non-alcoholic 
extract. Propolis is a resinous substance that bees 
collect, process and use as the building material 
in the beehive. It contains 50% balsam and resin, 
30% beeswax, 5% pollen, 10% essential oils 
and 5% other organic components. The last two 
include low molecular weight phenols that are 
considered to have biologically active properties, 
namely flavonoids, phenolic acids and esters, 
aromatic aldehydes and terpenoids (BANSKOTA 
et al., 2001; SILVA-CARVALHO et al., 2015). For 
medical purposes, propolis has been used for years 
- in ancient times the Egyptians used to balm and 
mummify the bodies of the dead, and in the records 
of the Greeks and Romans its use is described 
in the treatment of some skin diseases and for 
disinfection of wounds, for protection against 
infection, pain relief and reduction of swelling 
(CRANE, 1999). The biological effects of propolis 
are related to its antimicrobial, anti-inflammatory, 
and recently, antioxidant properties (BANSKOTA 
et al., 2001; ISLA et al., 2001; SILVA-CARVALHO 
at al., 2015) and due to its great potential role as 
free radical scavenger (PASCUAL et al., 1994). 
Active components from propolis may be effective 
in mastitis treatment (FIORDALISI et al., 2016), 
not just due to their antimicrobial activity, but 
also due to their antioxidant effects, since one of 
the contributing factors to subclinical infection 
aetiology and lower udder immune response is 
considered to be oxidative stress (BOUWSTRA et 
al., 2010).
On the basis of previous findings we treated 
animals with Apimast® - as a replacement for 
antibiotic treatment of subclinically present 
mastitis. The aim of this study was to investigate the 
effect of Apimast® intramammary administration 
on the antioxidant/oxidation markers (glutathione 
peroxidase (GSH-Px), ROM (reactive oxygen 
metabolites), SOD (superoxide dismutase), 
biological antioxidant potential (BAP), TAS (total 
antioxidant status), non-esterified fatty acids 
(NEFA) and beta hydroxybutyrate (BHB) in dairy 
cows, in order to elucidate some of the possible 
mechanisms of its action during mastitis. 
Materials and methods 
Animals and protocol. The research was 
conducted on three large dairy farms with the 
Holstein breed; Krndija (Farm 1), Grube (Farm 
2) and SNK milk (Farm 3). The study included 
10 dairy cows from each farm diagnosed with 
subclinical mastitis (in at least one udder quarter) 
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while ten healthy animals served as the control. The 
animals were kept on deep bedding, and fed with a 
standard feed (Table 1). 
Table 1. Mean chemical composition (g/100g of 

















Vitamin A, IU/kg 6700.0
Vitamin D, IU/kg 636.0
Vitamin E, IU/kg 18.7
Subclinical mastitis was screened before and after 
each propolis application by measuring the number 
of somatic cells (SCC) in the milk using a DeLaval 
(Tetra Laval, Sweden) device by optical somatic 
cell counting, by analysing milk yield data collected 
on the farm and using microbiological screening of 
milk samples in an accredited laboratory (Croatian 
Veterinary Institute, Zagreb) according to the 
recommendations described in the Laboratory 
Handbook on Bovine Mastitis (National Mastitis 
Council, 1999).
Apimast® was administered three times at 12 h 
intervals, in all four quarters: after the morning and 
evening milking, and the next day after the morning 
milking. 
Sample collection. Milk was sampled into 
labelled sterile plastic tubes from each quarter of 
dairy gland in a specific manner. Namely, after 
squirting the first milk stream, the tip of the teat 
was thoroughly disinfected with 70% alcohol. 
Samples were taken before the first application, 
12h after the first application, 12h after the second 
propolis application, and on the 7th day after the 
first propolis application. Milk samples were kept 
at 4 °C (microbiological screening) or at -20 °C 
(determination of oxidants and antioxidants) for a 
maximum of 24 hours. Milk samples collected from 
healthy animals were prepared and analysed as bulk 
(pooled). In order to determine the concentration 
of d-ROM, BAP, SOD, GSH-Px and TAS milk 
samples were prepared by a modified method 
based on BERMEJO et al. (1997) and EZAKI et 
al. (2008). In brief, milk samples were centrifuged 
in two phases. In the first stage, the milk was 
centrifuged for 15 minutes at 1600 rpm and, after 
separation of the cellular elements, the supernatant 
was centrifuged for 45 minutes at 10,000 rpm at 4 
°C. Following the described procedure, a sample of 
fat-removed milk was used to measure oxidative 
stress parameters.
Blood samples were taken before the first 
application and 48h after the first application 
of Apimast® into anticoagulant-free antisera 
tubes (Venosafe Biochemical Gel Tubes) (with 
the permission of the Ethics Committee of the 
Veterinary Faculty of the University of Zagreb, 
class: 640-01 / 15-179, No. 251-61-01 / 139-15-3 
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dated 22 April 2015). The control group samples 
were taken at the same time intervals. Blood samples 
were centrifuged at 3000 pm for 15 minutes, after 
which the serum was separated into several tubes 
and stored at -20 °C until analysis.
Apimast® formulations. Apimast® 1% and 3% 
formulations were used in the study, prepared by 
SME Hedera d.o.o. according to an innovative 
protected procedure (patent No. P20190325) of non-
alcoholic extraction from poplar type propolis. The 
raw material was collected from bee-keepers from 
Croatia, grinded, homogenized and mechanically 
purified prior to extraction. 
Biochemical tests. The GSH-Px activity 
was assessed using a commercial kit (Ransel, 
Randox Laboratories, Ireland). Briefly, GSH-Px 
activity was assessed indirectly at the absorbance 
wavelength of 340 nm for 5 minutes of NADPH 
oxidation to NADP+. The assay mixture consisted 
of 50 mM phosphate buffer with 0.4 mM EDTA 
and 1 mM sodium azide (pH = 7.0), 0.12 mM 
NADPH, 3.2 units of GR, 1 mM glutathione, and 
0.0007% (w/w) H2O2. One unit of GPx activity 
catalyses the oxidation by H2O2 of 1.0 μmol of 
reduced glutathione to oxidized glutathione per 
minute at pH = 7.0 and 25 °C. GSH-Px activity was 
calculated by using the molar extinction coefficient 
for NADPH disappearance (ε = 6220 dm3 mol-1 
cm-1). Serum and milk SOD activity was evaluated 
by the spectrophotometric method using the 
commercially available RANSOD kit (RANDOX 
Laboratories, UK). In this assay, xanthine and 
xanthine oxidase were used to generate superoxide 
anion radicals which react with 2-(4-iodophenyl)-
3-(4-nitrophenol)-5-phenyltetrazolium chloride 
quantitatively to form a red formazan dye. SOD 
inhibits the reaction by converting the superoxide 
radical to oxygen. Homogenized liver tissues, 
Fasciola spp. parasites and standard solutions 
were used for the assay of SOD. Absorbance was 
measured at 505 nm (Olympus AU640, Japan) for 
30s after the addition of xanthine oxidase as the start 
reagent, and 3 minutes after reaction as duplicate 
samples. NEFA, BHB, and glucose concentrations 
were also measured with commercially available 
Randox reagents on an Olympus AU640 (Olympus, 
Japan). The d-ROMs test (Diacron International, 
Italy) was carried out to assess the concentration of 
reactive oxygen metabolites in the milk samples. 
The method was carried out by monitoring at 505 nm 
the absorbance of solutions obtained by dissolving 
the milk samples (10 μL) in 1 mL of acetate buffer 
(pH 4.8) and adding 10 μL of a 3.7×10−1 M solution 
of the chromogen (DEPPD) (the absorbance values 
being converted to arbitrary Carr units) (DOTAN 
et al., 2004). According to the manufacturer’s 
specifications, the d-ROMs test readings are 
classified as follows: 250-300 Carr units: normal 
range; 300-320 Carr units: borderline condition; 
more than 320 Carr units: increasing oxidative stress 
condition. A control serum (320 Carr units) supplied 
with the kit was used for calibration of the test.
Quantification of TAS, as the measure of non-
quantitative antioxidant function in the milk 
samples, was carried out using ABTS (2,20-azinodi-
[3-ethylbenzothiazoline sulphonate]) formation 
kinetics. The commercially available colorimetric 
TAS assay (Randox Laboratories, UK) is based 
on the suppression of the absorbance of ABTS 
cation radicals by antioxidants in the test sample, 
when ABTS is incubated with a radical generating 
system (metmyoglobin + H2O2). A reaction mixture 
containing 100 μM H2O2, metmyoglobin and 610 
μM ABTS was incubated with 5 μM trolox at 37 °C. 
Namely, the method is calibrated with the vitamin 
E analogue, known as trolox equivalent, and the 
results are expressed in mmol/L. The spectra were 
recorded in time scan mode until the reaction 
reached a plateau.
BAP was assessed using a test kit from Diacron 
(Grosseto, Italy). This test provides a global 
measurement of many antioxidants, including 
uric acid, ascorbic acid, proteins, α-tocopherol, 
and bilirubin. Briefly, 10 μL sample is added to a 
solution of ferric chloride and thiocyanate derivate. 
The assay is based on the ability of a coloured 
thiocyanate-derived substrate, which contains 
bounded Fe3+ ions, to decolorize when Fe3+ ions 
are reduced to Fe2+. The absorbance is measured at 
505 nm. The level of change is used to calculate 
the ability of the sample to reduce ferric ions. The 
results are expressed as μEq ferric ions reducing 
antioxidants per L of sample (BENZIE and 
STRAIN, 1996).
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Statistical analysis. The results were categorized 
on the basis of the bacteriological status of the 
quarter: to a negative or a bacteriologically positive 
group. Results were analysed using GraphPad 8 and 
presented as mean ± standard deviation (SD). The 
distribution normality was checked by the Shapiro-
Wilks test. The significance of the differences in 
repeat measurements was verified by Kruskall-
Wallis's variation analysis and rank-level test, and 
the difference between the groups was analysed 
using the Mann-Whitney U test. The correlation 
between the observed indicators was tested by 
Spearman's correlation coefficient. Statistical 
significance was set at P≤0.05.
Results
The values of antioxidant enzymes (SOD, GSH-
PX), reactive oxygen metabolites (ROMs) and 
total antioxidant capacity (TAS, BAP) measured in 
cow's milk on Farms 1 and 2 after intramammary 
administration of 3% Apimast® are shown in Table 
2, while the values measured after 1% Apimast® 
administration are presented in Table 3. The values 
of biochemical and antioxidant ratios are shown in 
Table 4. The activity of the GSH-Px enzyme and 
the concentration of the total antioxidant potential 
(TAS) was statistically significantly increased 
after the 1st and 2nd 3% Apimast® administration 
compared to the initial value, while there was no 
change between the initial concentration of TAS 
and GSH-Px and its level on the 7th day after 
Apimast® administration. Other indicators did not 
change over time within the same farm. 
A high positive correlation between oxidative 
status in the milk of positive (P<0.05; r = 0.58) 
and negative (P<0.05; r = 0.51) quarters was found 
for GSH-Px and TAS activity, while for other 
indicators no correlation was found. There was also 
a statistically significant low (P<0.05; r = 0.33) 
correlation between the activity of GSH-Px and 
SOD in the milk and blood of all samples in total.
Metabolic status indicators NEFA (up to 0.14 ± 
0.09 mmol/L) and BHB (up to 0.35 ± 0.07 mmol/L) 
were below the cut-off limit for dairy cattle 
throughout the study period (Table 4). The glucose 
values were within the reference range. There was a 
statistically significant (P<0.05; r = 0.65) correlation 
between serum free fatty acid concentration and 
d-ROM in the milk of the dairy cattle.
Table 2. Mean ± SD values of oxidative stress markers on Farm 1 and 2, in bacteriologically negative quarters and 
positive quarters, at different time points before (0) or 12 h, 24 h and 7 days after 3% Apimast® intramammary 
administration 
Negative quarters Positive quarters



























































































* - significantly different from control (0 h) (P<0.05)
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Table 3. Mean ± SD values of oxidative stress markers on Farm 3, in bacteriologically negative quarters and positive 
quarters, at different time points before (0) or 12 h, 24 h and 7 days after 1% Apimast® intramammary administration 
Negative quarters Positive quarters
0 12 h 24 h 7 days 0 12 h 24 h 7 days
GSH-Px 
(U/L) 272 ± 16 319 ± 71 356 ± 69* 303 ± 84 326 ± 110 317 ± 89
 367 ± 121 284 ± 24
BAP 
(mmol/L) 6.2 ± 0.4 6.3 ± 0.2 6.3 ± 0.3 6.5 ± 0.4 6.3 ± 0.4 5.7 ± 1.2 5.1 ± 1.3 6.2 ± 0.3
 
dROM 
(U Carr) 573 ± 275 728 ± 209 779 ± 58* 526 ± 30 599 ± 227 540 ± 153 605 ± 30 533 ± 138 
SOD 
(U/L) 1.9 ± 0.8 2 ± 0.8 2 ± 0.6 1.9 ± 0.7 1.9 ± 0.7 1.5 ± 0.5 1.7 ± 1.4 1.8 ± 0.9 
GSH-Px/
SOD 0.2 ± 0.1
 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.5 ± 0.5 0.2 ± 0.1 
* - significantly different from control (0h) (P<0.05)
Table 4. Biochemical parameters and antioxidant enzymes in serum of cows before and after 3% and 1% Apimast® 
intramammary administration in positive or negative quarters
3% Apimast® 1% Apimast®
Negative Positive Negative Positive



























































































* - significantly different from control (0h) (P<0.05)
discussion 
There is undoubtedly a recognized role of 
oxidative stress in the pathogenesis of mastitis in 
ruminants (BOUWSTRA et al., 2010; ĐURIČIĆ 
et al., 2017; KLECZKOWSKI et al., 2017; 
LYKKESFELDT and SVEDSEN, 2007). Oxidative 
stress is defined as the shift of equilibrium in 
cellular oxidative-reduction reactions with 
enhancement of reactive oxygen species (ROS), 
resulting in unbalanced free radical formation, and 
finally in cell and tissue damage (CELI, 2011). 
Physiologically, free radicals are constantly formed 
in a cell as normal products of its metabolism, and 
in low concentrations are extremely important in 
multiple physiological processes (DRÖGE, 2002), 
such as phagocytosis, arachidonic acid metabolism, 
ovulation and fertilization (SINGH et al., 2004). 
However, when free radical formation is excessive, 
oxidative stress plays a significant role in the 
aetiology of various diseases, one of them being 
mastitis (ATAKISI et al., 2010; BOUWSTRA et al., 
2010; ĐURIČIĆ et al., 2017; KLECZKOWSKI et 
al., 2017). The search for reliable indicators of this 
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imbalance between pro-oxidants and antioxidants 
is an important on-going issue. While measurement 
of antioxidant enzymes SOD and GSH-Px and 
TAS is a "classical" method, new methods, such as 
a d-ROM and BAP determination which measure 
the total amount of antioxidants or substances 
capable of reducing iron in fero- and feri- form 
(BENZIE and STRAIN, 1996), are still not in 
common use. Given the relatively low spread of 
these tests in herd health research, reference ranges 
for these indicators in biological ruminant fluids 
do not exist. The normal range of d-ROM plasma 
values in humans is between 250 and 300 U Carr. 
However, in our study, values were 10 times lower 
than in humans (39.13 ± 20.73 U Carr to 77.32 ± 
10.22 U Carr), which corresponds to the findings 
of PASQUINI et al. (2008) in dogs, where they 
are between 56.4 - 91.4 U Carr, and in sheep 
(PICCIONE et al., 2006). In milk samples positively 
related to mastitis, we found no significant change 
in d-ROM concentrations in the milk. 3% Apimast® 
intramammary administration increased d-ROM 
levels in milk in negative and positive quarters, 
and 1% Apimast increased these levels in only the 
negative quarters. This possibly led to increased 
activation of some of the antioxidant mechanisms 
such as GSH-Px, also visible in Table 2 and 3. The 
positive correlation found between the NEFA and 
BHB concentrations in the blood and the d-ROM 
in milk suggests an increase in total oxidation (free 
radicals, but also non-radical oxygen compounds, 
such as H2O2, hypochlorous acid, etc.) as a 
response to fatty acid mobilization and potential 
lipid peroxidation (BERNABUCCI et al., 2005) in 
highly productive dairy animals.
Repeated measurements showed that BAP values 
after Apimast® administration over time remained 
at approximately the same levels, while TAS values 
increased significantly in all quartile groups after the 
1st and 2nd 3% Apimast® administration (regardless 
the presence of pathogenic microorganisms). No 
positive correlation between these two parameters 
was found in this study, which can be attributed 
to their different sensitivity in measuring the 
concentration/activity of compounds with 
antioxidant properties. Specifically, the BAP 
method is more appropriate for evaluating the 
efficacy of low molecular weight anitoxidation 
molecules (such as urinary or ascorbic acid). One 
of the few studies in which BAP was measured in 
milk in humans (EZAKI et al., 2008) has an average 
value of 3.85 ± 1.35 mmol/L, which is half the level 
found in this study (Table 2).
The effect of 3% Apimast® on the oxidative 
status of the udder was the same, regardless of the 
initial microbiological status of the quarter. After 
the Apimast® administration, the concentration of 
TAS significantly increased in all animals and in all 
quarters (Table 2), due to the statistically significant 
increase in the activity of the GSH-Px enzyme, with 
which a positive correlation was found (P<0.05; 
r = 0.58 in positive regions, P<0.05, r = 0.51 in 
negative) after the first and second Apimast® 
administration in all samples (Table 2).
Although the antioxidant and antibacterial 
effects of phenolic acids and poplar propolis are 
known, and many studies of its in vitro efficacy 
have been performed (BANSKOTA et al., 2001; 
ISLA et al., 2001; SHIMIZU et al., 2004), a smaller 
number of papers have demonstrated its efficacy 
in vivo (SILVA-CARVALHO et al., 2015). It is 
interesting that propolis samples taken at different 
geographic longitudes and latitudes around the 
globe have similar biological properties, regardless 
of differences in their composition (BANSKOTA 
et al., 2001). Preparations made from bee products 
that can be found on the market are obtained 
by various extraction methods that significantly 
contribute to the loss of active substances from 
primary raw materials, which consequently reduce 
their antioxidant and antimicrobial efficacy. The 
innovative technological concept for polyphenol 
extraction from poplar type propolis (patent No. 
P20190325) used in this research enables the 
preservation of the maximum activity of defined 
and standardized substances, and reproducible 
biological effects, compared to all the existing bee 
product formulations on the market, and certainly 
with respect to the antibiotics that are commonly 
used in farming (ŠURAN et al., 2016). Besides 
its antimicrobial efficacy, Apimast® has a positive 
effect on the antioxidant defence mechanisms of 
the udder, and may be regarded as non-antibiotic 
mastitis therapy as well.
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sAžeTAK
Cilj istraživanja bio je odrediti učinak nove intramamarne formulacije na bazi pčelinjih proizvoda, Apimasta®, na 
oksidacijski status muznih krava. Apimast® je apliciran u tri navrata s razmacima od 12 sati u 10 krava na tri različite 
farme. Izmjereni su markeri oksidacijskog statusa kao i određeni metabolički pokazatelji u mlijeku (GSH-Px, d-ROM, 
SOD, BAP, TAS) i serumu (SOD, GSH-Px, NEFA, BHB, glukoza). Učinak Apimasta® bio je uglavnom lokalan, bez 
obzira na primijenjenu koncentraciju (1 i 3 %), jer porast koncentracija GSH-Px i TAS-a u mlijeku nije pratio porast 
u serumu. Promjene svih mjerenih pokazatelja bile su kratkotrajne i nakon sedam dana vraćale su se na približne 
vrijednosti početnih koncentracija. U bakteriološki pozitivnim četvrtima vimena nije zabilježen porast ROM-a. Ovo 
istraživanje potvrđuje lokalni antioksidacijski učinak Apimasta® u vimenu, što je relevantno s aspekta neantibiotskog 
liječenja supkliničkog mastitisa. 
Ključne riječi: mastitis; oksidacijski stres; Apimast®; propolis; muzne krave_____________________________________________________________________________________________

